The role of zinc in Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Hooper, Nigel M ^a   Watt, Nicole T ^a   Whitehouse, Isobel J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CHELATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ZINC;

ALZHEIMER DISEASE; HUMAN; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; ZINC METABOLISM;

EID: 79251578940     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/971021     Document Type: Review

References (131)

1. Mount C., Downton C., Alzheimer disease: progress or profit? Nature Medicine 2006 12 7 780 784
2. Wimo A., Winblad B., Jnsson L., The worldwide societal costs of dementia: estimates for 2009 Alzheimer's and Dementia 2010 6 2 98 103
3. Selkoe D. J., Alzheimer's disease: genes, proteins, and therapy Physiological Reviews 2001 81 2 741 766
4. Hooper N. M., Hooper N. M., The biological roles of zinc and families of zinc metalloproteases Zinc Metalloproteases in Health and Disease 1996 London, UK Talor Francis 1 21
5. Danscher G., Jensen K. B., Frederickson C. J., Kemp K., Andreasen A., Juhl S., Stoltenberg M., Ravid R., Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material Journal of Neuroscience Methods 1997 76 1 53 59
6. Frederickson C. J., Danscher G., Zinc-containin neurons in hippocampus and related CNS structures Progress in Brain Research 1990 83 71 84
7. Frederickson C. J., Bush A. I., Synaptically released zinc: physiological functions and pathological effects BioMetals 2001 14 3-4 353 366
8. Slomianka L., Danscher G., Frederickson C. J., Labeling of the neurons of origin of zinc-containing pathways by intraperitoneal injections of sodium selenite Neuroscience 1990 38 3 843 854
9. Koh J. Y., Endogenous zinc in neurological diseases Journal of Clinical Neurology 2005 1 121 133
10. Tian Y., Yang Z., Zhang T., Zinc ion as modulator effects on excitability and synaptic transmission in hippocampal CA1 neurons in Wistar rats Neuroscience Research 2010 68 3 167 175
11. Lichten L. A., Cousins R. J., Mammalian zinc transporters: nutritional and physiologic regulation Annual Review of Nutrition 2009 29 153 176
12. McMahon R. J., Cousins R. J., Mammalian zinc transporters Journal of Nutrition 1998 128 4 667 670
13. Palmiter R. D., Cole T. B., Quaife C. J., Findley S. D., ZnT-3, a putative transporter of zinc into synaptic vesicles Proceedings of the National Academy of Sciences of the United States of America 1996 93 25 14934 14939
14. Linkous D. H., Flinn J. M., Koh J. Y., Lanzirotti A., Bertsch P. M., Jones B. F., Giblin L. J., Frederickson C. J., Evidence that the ZNT3 protein controls the total amount of elemental zinc in synaptic vesicles Journal of Histochemistry and Cytochemistry 2008 56 1 3 6
15. Cole T. B., Wenzel H. J., Kafer K. E., Schwartzkroin P. A., Palmiter R. D., Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1716 1721
16. Li Y., Hough C. J., Suh S. W., Sarvey J. M., Frederickson C. J., Rapid translocation of Zn2+ from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation Journal of Neurophysiology 2001 86 5 2597 2604
17. Thompson R. B., Whetsell W. O. Jr., Maliwal B. P., Fierke C. A., Frederickson C. J., Fluorescence microscopy of stimulated Zn(II) release from organotypic cultures of mammalian hippocampus using a carbonic anhydrase-based biosensor system Journal of Neuroscience Methods 2000 96 1 35 45
18. Frederickson C. J., Koh J. Y., Bush A. I., The neurobiology of zinc in health and disease Nature Reviews Neuroscience 2005 6 6 449 462
19. Bastian C., Li Y. V., Fluorescence imaging study of extracellular zinc at the hippocampal mossy fiber synapse Neuroscience Letters 2007 419 2 119 124
20. Quinta-Ferreira M. E., Matias C. M., Arif M., Dionsio J. C., Measurement of presynaptic zinc changes in hippocampal mossy fibers Brain Research 2004 1026 1 1 10
21. Paoletti P., Vergnano A. M., Barbour B., Casado M., Zinc at glutamatergic synapses Neuroscience 2009 158 1 126 136
22. Peters S., Koh J., Choi D. W., Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons Science 1987 236 4801 589 593
23. Westbrook G. L., Mayer M. L., Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons Nature 1987 328 6131 640 643
24. Christine C. W., Choi D. W., Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons Journal of Neuroscience 1990 10 1 108 116
25. Legendre P., Westbrook G. L., The inhibition of single N-methyl-D-aspartate-activated channels by zinc ions on cultured rat neurones Journal of Physiology 1990 429 429 449
26. Chen N., Moshaver A., Raymond L. A., Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition Molecular Pharmacology 1997 51 6 1015 1023
27. Paoletti P., Ascher P., Neyton J., High-affinity zinc inhibition of NMDA NR1-NR2A receptors Journal of Neuroscience 1997 17 15 5711 5725
28. Koh J. Y., Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors Neuroscience 1994 60 4 1049 1057
29. Weiss J. H., Hartley D. M., Koh J. Y., Choi D. W., AMPA receptor activation potentiates zinc neurotoxicity Neuron 1993 10 1 43 49
30. Lin D. D., Cohen A. S., Coulter D. A., Zinc-induced augmentation of excitatory synaptic currents and glutamate receptor responses in hippocampal CA3 neurons Journal of Neurophysiology 2001 85 3 1185 1196
31. Jia Y., Jeng J. M., Sensi S. L., Weiss J. H., Zn 2 + currents are mediated by calcium-permeable AMPA/kainate channels in cultured murine hippocampal neurones Journal of Physiology 2002 543 1 35 48
32. Mathie A., Sutton G. L., Clarke C. E., Veale E. L., Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability Pharmacology and Therapeutics 2006 111 3 567 583
33. Magistretti J., Castelli L., Taglietti V., Tanzi F., Dual effect of Zn2+ on multiple types of voltage-dependent Ca currents in rat palaeocortical neurons Neuroscience 2003 117 2 249 264
34. Sun H. S., Hui K., Lee D. W. K., Feng Z. P., Zn 2 + sensitivity of high- and low-voltage activated calcium channels Biophysical Journal 2007 93 4 1175 1183
35. Inoue K., Branigan D., Xiong Z. G., Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels The Journal of Biological Chemistry 2010 285 10 7430 7439
36. Molnr P., Nadler J. V., Synaptically-released zinc inhibits N-methyl-D-aspartate receptor activation at recurrent mossy fiber synapses Brain Research 2001 910 1-2 205 207
37. Vogt K., Mellor J., Tong G., Nicoll R., The actions of synaptically released zinc at hippocampal mossy fiber synapses Neuron 2000 26 1 187 196
38. Ueno S., Tsukamoto M., Hirano T., Kikuchi K., Yamada M. K., Nishiyama N., Nagano T., Matsuki N., Ikegaya Y., Mossy fiber Zn2+ spillover modulates heterosynaptic N-methyl-D-aspartate receptor activity in hippocampal CA3 circuits Journal of Cell Biology 2002 158 2 215 220
39. Lu Y. M., Taverna F. A., Tu R., Endogenous Zn2+ is required for the induction of long-term potentiation at rat hippocampal mossy fiber-CA3 synapses Synapse 2000 38 2 187 197
40. Kay A. R., Tth K., Influence of location of a fluorescent zinc probe in brain slices on its response to synaptic activation Journal of Neurophysiology 2006 95 3 1949 1956
41. Kay A. R., Evidence for chelatable zinc in the extracellular space of the hippocampus, but little evidence for synaptic release of Zn Journal of Neuroscience 2003 23 17 6847 6855
42. Yamasaki S., Sakata-Sogawa K., Hasegawa A., Suzuki T., Kabu K., Sato E., Kurosaki T., Yamashita S., Tokunaga M., Nishida K., Hirano T., Zinc is a novel intracellular second messenger Journal of Cell Biology 2007 177 4 637 645
43. Leissring M. A., The A Cs of A -cleaving proteases The Journal of Biological Chemistry 2008 283 44 29645 29649
44. Bush A. I., Multhaup G., Moir R. D., Williamson T. G., Small D. H., Rumble B., Pollwein P., Beyreuther K., Masters C. L., A novel zinc(II) binding site modulates the function of the A4 amyloid protein precursor of Alzheimer's disease The Journal of Biological Chemistry 1993 268 22 16109 16112
45. Bush A. I., Pettingell W. H., De Paradis M., Tanzi R. E., Wasco W., The amyloid -protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily The Journal of Biological Chemistry 1994 269 43 26618 26621
46. Multhaup G., Busha A. I., Pollweina P., Masters C. L., Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease A4 amyloid precursor protein (APP) FEBS Letters 1994 355 2 151 154 (Pubitemid 24355107)
47. Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Bill E., Pipkorn R., Masters C. L., Beyreuther K., Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide Biochemistry 1998 37 20 7224 7230
48. Chow V. W., Mattson M. P., Wong P. C., Gleichmann M., An overview of APP processing enzymes and products Neuromolecular Medicine 2010 12 1 1 12
49. Edbauer D., Winkler E., Regula J. T., Pesold B., Steiner H., Haass C., Reconstitution of -secretase activity Nature Cell Biology 2003 5 5 486 488
50. Nikolaev A., McLaughlin T., O'Leary D. D. M., Tessier-Lavigne M., APP binds DR6 to trigger axon pruning and neuron death via distinct caspases Nature 2009 457 7232 981 989
51. Somnicki. P., Leniak W., A putative role of the Amyloid Precursor Protein Intracellular Domain (AICD) in transcription Acta Neurobiologiae Experimentalis 2008 68 2 219 228
52. Edwards D. R., Handsley M. M., Pennington C. J., The ADAM metalloproteinases Molecular Aspects of Medicine 2009 29 5 258 289
53. Bode W., Gomis-Ruth F. X., Stockler W., Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the metzincins FEBS Letters 1993 331 1-2 134 140
54. Gomis-Rth F. X., Structural aspects of the metzincin clan of metalloendopeptidases Applied Biochemistry and Biotechnology Part B 2003 24 2 157 202
55. Allinson T. M. J., Parkin E. T., Turner A. J., Hooper N. M., ADAMs family members as amyloid precursor protein alpha-secretases Journal of Neuroscience Research 2003 74 3 342 352
56. Asai M., Hattori C., Szab B., Sasagawa N., Maruyama K., Tanuma S. I., Ishiura S., Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase Biochemical and Biophysical Research Communications 2003 301 1 231 235
57. Fahrenholz F., Gilbert S., Kojro E., Lammich S., Postina R., -Secretase activity of the disintegrin metalloprotease ADAM 10: influences of domain structure Annals of the New York Academy of Sciences 2000 920 215 222
58. Tanabe C., Hotoda N., Sasagawa N., Sehara-Fujisawa A., Maruyama K., Ishiura S., ADAM19 is tightly associated with constitutive Alzheimer's disease APP -secretase in A172 cells Biochemical and Biophysical Research Communications 2007 352 1 111 117
59. Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojro E., Prinzen C., Endres K., Hiemke C., Blessing M., Flamez P., Dequenne A., Godaux E., Van Leuven F., Fahrenholz F., A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alheizmer disease mouse model Journal of Clinical Investigation 2004 113 10 1456 1464
60. Hartmann D., de Strooper B., Serneels L., Craessaerts K., Herreman A. N., Annaert W., Umans L., Lbke T., Illert A. L., Von Figura K., Saftig P., The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for -secretase activity in fibroblasts Human Molecular Genetics 2002 11 21 2615 2624
61. Kuhn P.-H., Wang H., Dislich B., Colombo A., Zeitschel U., Ellwart J. W., Kremmer E., Roner S., Lichtenthaler S. F., ADAM10 is the physiologically relevant, constitutive -secretase of the amyloid precursor protein in primary neurons EMBO Journal 2010 29 17 3020 3032
62. Bateman R. J., Munsell L. Y., Morris J. C., Swarm R., Yarasheski K. E., Holtzman D. M., Human amyloid- synthesis and clearance rates as measured in cerebrospinal fluid in vivo Nature Medicine 2006 12 7 856 861
63. El-Amouri S. S., Zhu H., Yu J., Marr R., Verma I. M., Kindy M. S., Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease American Journal of Pathology 2008 172 5 1342 1354
64. Hersh L. B., Rodgers D. W., Neprilysin and amyloid beta peptide degradation Current Alzheimer Research 2008 5 2 225 231
65. Miners J. S., Baig S., Palmer J., Palmer L. E., Kehoe P. G., Love S., A -degrading enzymes in Alzheimer's disease Brain Pathology 2008 18 2 240 252
66. Vardy E. R. L. C., Catto A. J., Hooper N. M., Proteolytic mechanisms in amyloid- metabolism: therapeutic implications for Alzheimer's disease Trends in Molecular Medicine 2005 11 10 464 472
67. Kanemitsu H., Tomiyama T., Mori H., Human neprilysin is capable of degrading amyloid peptide not only in the monomeric form but also the pathological oligomeric form Neuroscience Letters 2003 350 2 113 116
68. Apelt J., Ach K., Schliebs R., Aging-related down-regulation of neprilysin, a putative -amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of -amyloid plaques Neuroscience Letters 2003 339 3 183 186
69. Farris W., Schtz S. G., Cirrito J. R., Shankar G. M., Sun X., George A., Leissring M. A., Walsh D. M., Wei Q. Q., Holtzman D. M., Selkoe D. J., Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy American Journal of Pathology 2007 171 1 241 251
70. Akiyama H., Kondo H., Ikeda K., Kato M., McGeer P. L., Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid -protein (A ) deposition Brain Research 2001 902 2 277 281
71. Eckman E. A., Adams S. K., Troendle F. J., Stodola B. A., Kahn M. A., Fauq A. H., Xiao H. D., Bernstein K. E., Eckman C. B., Regulation of steady-state -amyloid levels in the brain by neprilysin and endothelin- converting enzyme but not angiotensin-converting enzyme The Journal of Biological Chemistry 2006 281 41 30471 30478
72. Hellstrm-Lindahl E., Ravid R., Nordberg A., Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A levels Neurobiology of Aging 2008 29 2 210 221
73. Duckworth W. C., Bennett R. G., Hamel F. G., A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase The Journal of Biological Chemistry 1994 269 40 24575 24580
74. Vekrellis K., Ye Z., Qiu W. Q., Walsh D., Hartley D., Chesneau V., Rosner M. R., Selkoe D. J., Neurons regulate extracellular levels of amyloid -protein via proteolysis by insulin-degrading enzyme Journal of Neuroscience 2000 20 5 1657 1665
75. Wang S., Wang R., Chen L., Bennett D. A., Dickson D. W., Wang D.-S., Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain Journal of Neurochemistry 2010 115 1 47 57
76. Leal M. C., Dorfman V. B., Gamba A. F., Frangione B., Wisniewski T., Castao E. M., Sigurdsson E. M., Morelli L., Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic Tg2576 mice with Alzheimer pathology Journal of Neuropathology and Experimental Neurology 2006 65 10 976 987
77. Miller B. C., Eckman E. A., Sambamurti K., Dobbs N., Martin Chow K., Eckman C. B., Hersh L. B., Thiele D. L., Amyloid- peptide levels in brain are inversely correlated with insulysin activity levels in vivo Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6221 6226
78. Davenport A. P., Kuc R. E., Mockridge J. W., Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells Journal of Cardiovascular Pharmacology 1998 31 supplement 1 S1 S3
79. Yin K. J., Cirrito J. R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F. F., Turk J., Xu J., Hsu C. Y., Mills J. C., Holtzman D. M., Lee J. M., Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid- peptide catabolism Journal of Neuroscience 2006 26 43 10939 10948
80. Falkevall A., Alikhani N., Bhushan S., Pavlov P. F., Busch K., Johnson K. A., Eneqvist T., Tjernberg L., Ankarcrona M., Glaser E., Degradation of the amyloid -protein by the novel mitochondrial peptidasome, PreP The Journal of Biological Chemistry 2006 281 39 29096 29104 (Pubitemid 44507053)
81. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R., Copper, iron and zinc in Alzheimer's disease senile plaques Journal of the Neurological Sciences 1998 158 1 47 52
82. Lee J. Y., Cole T. B., Palmiter R. D., Suh S. W., Koh J. Y., Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice Proceedings of the National Academy of Sciences of the United States of America 2002 99 11 7705 7710
83. Bush A. I., Pettingell W. H., Multhaup G., Paradis D. M., Vonsattel J. P., Gusella J. F., Beyreuther K., Masters C. L., Tanzi R. E., Rapid induction of Alzheimer A amyloid formation by zinc Science 1994 265 5177 1464 1467
84. Lim K. H., Kim Y. K., Chang Y. T., Investigations of the molecular mechanism of metal-induced A (140) amyloidogenesis Biochemistry 2007 46 47 13523 13532
85. Miller L. M., Wang Q., Telivala T. P., Smith R. J., Lanzirotti A., Miklossy J., Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with -amyloid deposits in Alzheimer's disease Journal of Structural Biology 2006 155 1 30 37
86. Kozin S. A., Zirah S., Rebuffat S., Hui Bon Hoa G., Debey P., Zinc binding to Alzheimer's A (1-16) peptide results in stable soluble complex Biochemical and Biophysical Research Communications 2001 285 4 959 964
87. Mekmouche Y., Coppel Y., Hochgrfe K., Guilloreau L., Talmard C., Mazarguil H., Faller P., Characterization of the ZnII binding to the peptide amyloid- 1-16 linked to Alzheimer's disease ChemBioChem 2005 6 9 1663 1671
88. Syme C. D., Viles J. H., Solution H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (A ) of Alzheimer's disease Biochimica et Biophysica Acta 2006 1764 2 246 256
89. Talmard C., Bouzan A., Faller P., Zinc binding to amyloid- : isothermal titration calorimetry and Zn competition experiments with Zn sensors Biochemistry 2007 46 47 13658 13666
90. Zirah S., Kozin S. A., Mazur A. K., Blond A., Cheminant M., Sgalas-Milazzo I., Debey P., Rebuffat S., Structural changes of region 1-16 of the Alzheimer disease amyloid -peptide upon zinc binding and in vitro aging The Journal of Biological Chemistry 2006 281 4 2151 2161
91. Faller P., Hureau C., Bioinorganic chemistry of copper and zinc ions coordinated to amyloid- peptide Dalton Transactions 2009 7 1080 1094
92. Talmard C., Guilloreau L., Coppel Y., Mazarguil H., Faller P., Amyloid-beta peptide forms monomeric complexes with CuII and ZnII prior to aggregation ChemBioChem 2007 8 2 163 165
93. Danielsson J., Pierattelli R., Banci L., Grslund A., High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid -peptide FEBS Journal 2007 274 1 46 59
94. Zirah S., Rebuffat S., Kozin S. A., Debey P., Fournier F., Lesage D., Tabet J. C., Zinc binding properties of the amyloid fragment A (116) studied by electrospray-ionization mass spectrometry International Journal of Mass Spectrometry 2003 228 2-3 999 1016
95. Curtain C. C., Ali F., Volitakis I., Cherny R. A., Norton R. S., Beyreuther K., Barrow C. J., Masters C. L., Bush A. I., Barnham K. J., Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits The Journal of Biological Chemistry 2001 276 23 20466 20473
96. Liu S. T., Howlett G., Barrow C. J., Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A peptide of Alzheimer's disease Biochemistry 1999 38 29 9373 9378
97. Yang D. S., McLaurin J., Qin K., Westaway D., Fraser P. E., Examining the zinc binding site of the amyloid- peptide European Journal of Biochemistry 2000 267 22 6692 6698
98. Dong J., Atwood C. S., Anderson V. E., Siedlak S. L., Smith M. A., Perry G., Carey P. R., Metal binding and oxidation of amyloid- within isolated senile plaque cores: raman microscopic evidence Biochemistry 2003 42 10 2768 2773
99. Garzon-Rodriguez W., Yatsimirsky A. K., Glabe C. G., Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A peptide studied by fluorescence Bioorganic and Medicinal Chemistry Letters 1999 9 15 2243 2248
100. Ricchelli F., Drago D., Filippi B., Tognon G., Zatta P., Aluminum-triggered structural modifications and aggregation of -amyloids Cellular and Molecular Life Sciences 2005 62 15 1724 1733
101. Tugu V., Karafin A., Palumaa P., Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid- peptide Journal of Neurochemistry 2008 104 5 1249 1259
102. Rulon L. L., Robertson J. D., Lovell M. A., Deibel M. A., Ehmann W. D., Markesbery W. R., Serum zinc levels and Alzheimer's disease Biological Trace Element Research 2000 75 13 79 85
103. Jimnez-Jimnez F. J., Molina J. A., Aguilar M. V., Meseguer I., Mateos-Vega C. J., Gonzlez-Muoz M. J., De Bustos F., Martnez-Salio A., Ort-Pareja M., Zurdo M., Martnez-Para M. C., Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease Journal of Neural Transmission 1998 105 4-5 497 505 (Pubitemid 28365032)
104. Jeandel C., Nicolas M. B., Dubois F., Nabet-Belleville F., Penin F., Cuny G., Lipid peroxidation and free radical scavengers in Alzheimer's disease Gerontology 1989 35 5-6 275 282
105. Baum L., Chan I. H. S., Cheung S. K. K., Goggins W. B., Mok V., Lam L., Leung V., Hui E., Ng C., Woo J., Chiu H. F. K., Zee B. C. Y., Cheng W., Chan M. H., Szeto S., Lui V., Tsoh J., Bush A. I., Lam C. W. K., Kwok T., Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability BioMetals 2010 23 1 173 179
106. Lovell M. A., Smith J. L., Xiong S., Markesbery W. R., Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease Neurotoxicity Research 2005 7 4 265 271
107. Smith J. L., Xiong S., Markesbery W. R., Lovell M. A., Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain Neuroscience 2006 140 3 879 888
108. Lovell M. A., A potential role for alterations of zinc and zinc transport proteins in the progression of alzheimer's disease Journal of Alzheimer's Disease 2009 16 3 471 483
109. Smith M. A., Harris P. L. R., Sayre L. M., Perry G., Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proceedings of the National Academy of Sciences of the United States of America 1997 94 18 9866 9868
110. Butterfield D. A., Reed T., Newman S. F., Sultana R., Roles of amyloid -peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment Free Radical Biology and Medicine 2007 43 5 658 677
111. Clements A., Allsop D., Walsh D. M., Williams C. H., Aggregation and metal-binding properties of mutant forms of the amyloid A peptide of Alzheimer's disease Journal of Neurochemistry 1996 66 2 740 747
112. Esler W. P., Stimson E. R., Jennings J. M., Ghilardi J. R., Mantyh P. W., Maggio J. E., Zinc-induced aggregation of human and rat -amyloid peptides in vitro Journal of Neurochemistry 1996 66 2 723 732
113. Dong J., Shokes J. E., Scott R. A., Lynn D. G., Modulating amyloid self-assembly and fibril morphology with Zn(II) Journal of the American Chemical Society 2006 128 11 3540 3542
114. Miller Y., Ma B., Nussinov R., Zinc ions promote Alzheimer a aggregation via population shift of polymorphic states Proceedings of the National Academy of Sciences of the United States of America 2010 107 21 9490 9495
115. Deshpande A., Kawai H., Metherate R., Glabe C. G., Busciglio J., A role for synaptic zinc in activity-dependent a oligomer formation and accumulation at excitatory synapses Journal of Neuroscience 2009 29 13 4004 4015
116. Cherny R. A., Legg J. T., McLean C. A., Fairlie D. P., Huang X., Atwood C. S., Beyreuther K., Tanzi R. E., Masters C. L., Bush A. I., Aqueous dissolution of Alzheimer's disease A amyloid deposits by biometal depletion The Journal of Biological Chemistry 1999 274 33 23223 23228
117. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A., Barnham K. J., Volitakis I., Fraser F. W., Kim Y.-S., Huang X., Goldstein L. E., Moir R. D., Lim J. T., Beyreuther K., Zheng H., Tanzi R. E., Masters C. L., Bush A. I., Treatment with a copper-zinc chelator markedly and rapidly inhibits -amyloid accumulation in Alzheimer's disease transgenic mice Neuron 2001 30 3 665 676
118. Opazo C., Luza S., Villemagne V. L., Volitakis I., Rowe C., Barnham K. J., Strozyk D., Masters C. L., Cherny R. A., Bush A. I., Radioiodinated clioquinol as a biomarker for -amyloid: Zn2+ complexes in Alzheimer's disease Aging Cell 2006 5 1 69 79
119. Ritchie C. W., Bush A. I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.-X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R. E., Masters C. L., Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial Archives of Neurology 2003 60 12 1685 1691
120. Mancino A. M., Hindo S. S., Kochi A., Lim M. H., Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited Inorganic Chemistry 2009 48 20 9596 9598
121. Lannfelt L., Blennow K., Zetterberg H., Batsman S., Ames D., Harrison J., Masters C. L., Targum S., Bush A. I., Murdoch R., Wilson J., Ritchie C. W., Safety, efficacy, and biomarker findings of PBT2 in targeting A as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial The Lancet Neurology 2008 7 9 779 786
122. Mo Z. Y., Zhu Y. Z., Zhu H. L., Fan J. B., Chen J., Liang Y., Low micromolar zinc accelerates the fibrillization of human Tau via bridging of Cys-291 and Cys-322 The Journal of Biological Chemistry 2009 284 50 34648 34657
123. An W. L., Bjorkdahl C., Liu R., Cowburn R. F., Winblad B., Pei J. J., Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3 in SH-SY5Y neuroblastoma cells Journal of Neurochemistry 2005 92 5 1104 1115
124. Cole T. B., Martyanova A., Palmiter R. D., Removing zinc from synaptic vesicles does not impair spatial learning, memory, or sensorimotor functions in the mouse Brain Research 2001 891 1-2 253 265
125. Adlard P. A., Parncutt J. M., Finkelstein D. I., Bush A. I., Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? Journal of Neuroscience 2010 30 5 1631 1636
126. Schmitt-Ulms G., Ehsani S., Watts J. C., Westaway D., Wille H., Evolutionary descent of prion genes from the ZIP family of metal Ion transporters PLoS ONE 2009 4 9
127. Duce J. A., Tsatsanis A., Cater M. A., James S. A., Robb E., Wikhe K., Leong S. L., Perez K., Johanssen T., Greenough M. A., Cho H.-H., Galatis D., Moir R. D., Masters C. L., McLean C., Tanzi R. E., Cappai R., Barnham K. J., Ciccotosto G. D., Rogers J. T., Bush A. I., Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 2010 142 6 857 867
128. Whitehouse I. J., Jackson C., Turner A. J., Hooper N. M., Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's Disease The Journal of Alzheimer's Disease 2010 22 1023 1031
129. Parkin E. T., Watt N. T., Hussain I., Eckman E. A., Eckman C. B., Manson J. C., Baybutt H. N., Turner A. J., Hooper N. M., Cellular prion protein regulates -secretase cleavage of the Alzheimer's amyloid precursor protein Proceedings of the National Academy of Sciences of the United States of America 2007 104 26 11062 11067
130. Watt N. T., Taylor D. R., Gillott A., Thomas D. A., Perera W. S. S., Hooper N. M., Reactive oxygen species-mediated -clevage of the prion protein in the cellular response to oxidative stress The Journal of Biological Chemistry 2005 280 43 35914 35921
131. Haigh C. L., Drew S. C., Boland M. P., Meaters C. L., Barnham K. J., Lawson V. A., Collins S. J., Dominant roles of the polybasic proline motif and copper in the PrP23-89-mediated stress protection response Journal of Cell Science 2009 122 10 1518 1528